vs
Side-by-side financial comparison of ICU MEDICAL INC (ICUI) and Quad/Graphics, Inc. (QUAD). Click either name above to swap in a different company.
Quad/Graphics, Inc. is the larger business by last-quarter revenue ($630.6M vs $540.7M, roughly 1.2× ICU MEDICAL INC). On growth, Quad/Graphics, Inc. posted the faster year-over-year revenue change (-11.0% vs -14.1%). Quad/Graphics, Inc. produced more free cash flow last quarter ($137.2M vs $36.0M). Over the past eight quarters, Quad/Graphics, Inc.'s revenue compounded faster (-1.9% CAGR vs -2.3%).
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...
Quad is an American marketing services company headquartered in Sussex, Wisconsin. It provides a range of print and marketing services that support physical and digital media channels through audience targeting services, omnichannel media planning and placement, creative and content production, retail display and packaging, postal optimization, and consumer analytics. In 2025, Quad ranked as one of the largest agency companies in the U.S. and as one of the largest commercial printers in North...
ICUI vs QUAD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $540.7M | $630.6M |
| Net Profit | $-15.7M | — |
| Gross Margin | 37.5% | 21.6% |
| Operating Margin | 1.0% | 5.9% |
| Net Margin | -2.9% | — |
| Revenue YoY | -14.1% | -11.0% |
| Net Profit YoY | 34.0% | — |
| EPS (diluted) | $-0.63 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $540.7M | $630.6M | ||
| Q3 25 | $537.0M | $588.0M | ||
| Q2 25 | $548.9M | $571.9M | ||
| Q1 25 | $604.7M | $629.4M | ||
| Q4 24 | $629.8M | $708.4M | ||
| Q3 24 | $589.1M | $674.8M | ||
| Q2 24 | $596.5M | $634.2M | ||
| Q1 24 | $566.7M | $654.8M |
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $-3.4M | $10.2M | ||
| Q2 25 | $35.3M | $-100.0K | ||
| Q1 25 | $-15.5M | $5.8M | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-33.0M | $-24.7M | ||
| Q2 24 | $-21.4M | $-2.8M | ||
| Q1 24 | $-39.5M | $-28.1M |
| Q4 25 | 37.5% | 21.6% | ||
| Q3 25 | 37.4% | 22.8% | ||
| Q2 25 | 37.9% | 21.6% | ||
| Q1 25 | 34.7% | 20.6% | ||
| Q4 24 | 36.1% | 22.4% | ||
| Q3 24 | 34.8% | 21.8% | ||
| Q2 24 | 34.8% | 22.1% | ||
| Q1 24 | 32.7% | 20.4% |
| Q4 25 | 1.0% | 5.9% | ||
| Q3 25 | 2.6% | 4.5% | ||
| Q2 25 | 1.9% | 2.4% | ||
| Q1 25 | 2.1% | 3.1% | ||
| Q4 24 | 6.0% | 2.8% | ||
| Q3 24 | 1.4% | -0.7% | ||
| Q2 24 | 1.3% | 2.4% | ||
| Q1 24 | -1.9% | -1.6% |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -0.6% | 1.7% | ||
| Q2 25 | 6.4% | -0.0% | ||
| Q1 25 | -2.6% | 0.9% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.6% | -3.7% | ||
| Q2 24 | -3.6% | -0.4% | ||
| Q1 24 | -7.0% | -4.3% |
| Q4 25 | $-0.63 | $0.22 | ||
| Q3 25 | $-0.14 | $0.21 | ||
| Q2 25 | $1.43 | $0.00 | ||
| Q1 25 | $-0.63 | $0.11 | ||
| Q4 24 | $-0.97 | $0.11 | ||
| Q3 24 | $-1.35 | $-0.52 | ||
| Q2 24 | $-0.88 | $-0.06 | ||
| Q1 24 | $-1.63 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $63.3M |
| Total DebtLower is stronger | — | $369.9M |
| Stockholders' EquityBook value | $2.1B | $-59.5M |
| Total Assets | $4.1B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $63.3M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $6.7M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | $308.6M | $29.2M | ||
| Q3 24 | $312.5M | $12.5M | ||
| Q2 24 | $302.6M | $12.8M | ||
| Q1 24 | $251.4M | $10.2M |
| Q4 25 | — | $369.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $377.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.1B | $-59.5M | ||
| Q3 25 | $2.1B | $96.7M | ||
| Q2 25 | $2.1B | $87.0M | ||
| Q1 25 | $2.0B | $87.4M | ||
| Q4 24 | $2.0B | $-131.2M | ||
| Q3 24 | $2.0B | $50.9M | ||
| Q2 24 | $2.0B | $79.1M | ||
| Q1 24 | $2.1B | $89.2M |
| Q4 25 | $4.1B | $1.3B | ||
| Q3 25 | $4.1B | $1.3B | ||
| Q2 25 | $4.1B | $1.2B | ||
| Q1 25 | $4.2B | $1.2B | ||
| Q4 24 | $4.2B | $1.3B | ||
| Q3 24 | $4.3B | $1.4B | ||
| Q2 24 | $4.3B | $1.4B | ||
| Q1 24 | $4.3B | $1.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.6M | $145.9M |
| Free Cash FlowOCF − Capex | $36.0M | $137.2M |
| FCF MarginFCF / Revenue | 6.6% | 21.8% |
| Capex IntensityCapex / Revenue | 4.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $91.8M | $50.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.6M | $145.9M | ||
| Q3 25 | $56.7M | $-8.4M | ||
| Q2 25 | $11.2M | $47.4M | ||
| Q1 25 | $51.3M | $-89.0M | ||
| Q4 24 | $40.2M | $158.8M | ||
| Q3 24 | $36.1M | $2.4M | ||
| Q2 24 | $82.0M | $3.9M | ||
| Q1 24 | $45.8M | $-52.2M |
| Q4 25 | $36.0M | $137.2M | ||
| Q3 25 | $27.6M | $-20.6M | ||
| Q2 25 | $-8.5M | $34.4M | ||
| Q1 25 | $36.7M | $-100.3M | ||
| Q4 24 | $16.1M | $147.3M | ||
| Q3 24 | $16.2M | $-9.8M | ||
| Q2 24 | $62.5M | $-11.7M | ||
| Q1 24 | $29.9M | $-70.1M |
| Q4 25 | 6.6% | 21.8% | ||
| Q3 25 | 5.1% | -3.5% | ||
| Q2 25 | -1.5% | 6.0% | ||
| Q1 25 | 6.1% | -15.9% | ||
| Q4 24 | 2.6% | 20.8% | ||
| Q3 24 | 2.7% | -1.5% | ||
| Q2 24 | 10.5% | -1.8% | ||
| Q1 24 | 5.3% | -10.7% |
| Q4 25 | 4.6% | 1.4% | ||
| Q3 25 | 5.4% | 2.1% | ||
| Q2 25 | 3.6% | 2.3% | ||
| Q1 25 | 2.4% | 1.8% | ||
| Q4 24 | 3.8% | 1.6% | ||
| Q3 24 | 3.4% | 1.8% | ||
| Q2 24 | 3.3% | 2.5% | ||
| Q1 24 | 2.8% | 2.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.82× | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | -15.34× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
QUAD
| Catalog Publications Retail Inserts Books And Directories | $300.6M | 48% |
| Direct Mail And Other Printed Products | $147.1M | 23% |
| Imaging Marketing Services And Other Services | $79.8M | 13% |
| Logistic Services | $61.4M | 10% |
| Other | $39.3M | 6% |
| Other Revenues | $2.4M | 0% |
